UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | R | S | T | U | V | W
Number of items: 96.

A

Aballea, S; Chancellor, JVM; Raikou, M; Drummond, MF; Weinstein, MC; Jourdan, S; Bridgewater, J; (2007) Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US. CANCER , 109 (6) pp. 1082-1089. 10.1002/cncr.22512.

Aguilar, V; Alliouachene, S; Sotiropoulos, A; Sobering, A; Athea, Y; Djouadi, F; Miraux, S; (2007) S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab , 5 (6) pp. 476-487. 10.1016/j.cmet.2007.05.006.

Ah-See, M-L.W.; (2007) Evaluation of the vascular response to neoadjuvant chemotherapy in primary breast cancer. Doctoral thesis, University of London. Green open access
file

Ahmed, AA; Mills, AD; Ibrahim, AE; Temple, J; Blenkiron, C; Vias, M; Massie, CE; (2007) The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell , 12 (6) pp. 514-527. 10.1016/j.ccr.2007.11.014.

Al-Alwan, MM; Okkenhaug, K; Vanhaesebroeck, B; Hayflick, JS; Marshall, AJ; (2007) Requirement for phosphoinositide 3-kinase p110 delta signaling in B cell antigen receptor-mediated antigen presentation. JOURNAL OF IMMUNOLOGY , 178 (4) pp. 2328-2335.

Allen, OR; Gott, AL; Hartley, JA; Hartley, JM; Knox, RJ; McGowan, PC; (2007) Functionalised cyclopentadienyl titanium compounds as potential anticancer drugs. DALTON T (43) 5082 - 5090. 10.1039/b708283p.

Arkenau, HT; Chong, G; Cunningham, D; Watkins, D; Agarwal, R; Sirohi, B; Trumper, M; (2007) The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. Ann Oncol , 18 (3) pp. 541-545. 10.1093/annonc/mdl434.

Arkenau, HT; Chong, G; Cunningham, D; Watkins, D; Sirohi, B; Chau, I; Wotherspoon, A; (2007) Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. Haematologica , 92 (2) pp. 271-272.

Arkenau, HT; Chua, YJ; Cunningham, D; (2007) Current treatment strategies in elderly patients with metastatic colorectal cancer. Clin Colorectal Cancer , 6 (7) pp. 508-515.

Arkenau, HT; Gordon, C; Cunningham, D; Norman, A; Wotherspoon, A; Chau, I; (2007) Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience. Leuk Lymphoma , 48 (3) pp. 547-550. 10.1080/10428190601094388.

Arkenau, HT; Gordon, C; Murphy, F; Cunningham, D; (2007) Paraneoplastic syndrome: subacute cerebellar degeneration in Hodgkin's disease. Leuk Lymphoma , 48 (4) pp. 819-822. 10.1080/10428190601164249.

Ayaru, L; Pereira, SP; Alisa, A; Pathan, AA; Williams, R; Davidson, B; Burroughs, AK; (2007) Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization. J IMMUNOL , 178 (3) 1914 - 1922.

B

Bilanges, B; Argonza-Barrett, R; Kolesnichenko, M; Skinner, C; Nair, M; Chen, M; Stokoe, D; (2007) Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent manner. Mol Cell Biol , 27 (16) pp. 5746-5764. 10.1128/MCB.02136-06.

Bilanges, B; Stokoe, D; (2007) Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene , 26 (41) pp. 5973-5990. 10.1038/sj.onc.1210431.

Birney, E; Stamatoyannopoulos, JA; Dutta, A; Guigo, R; Gingeras, TR; Margulies, EH; Weng, ZP; (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. NATURE , 447 (7146) 799 - 816. 10.1038/nature05874.

Boone, J.J.M.; (2007) The role of ErbB2 and BRCA1 in repair of drug-induced DNA damage. Doctoral thesis, University of London. Green open access
file

Brown, T; Taherbhai, Z; Sexton, J; Sutterfield, A; Turlington, M; Jones, J; Stallings, L; (2007) Synthesis and biophysical evaluation of minor-groove binding C-terminus modified pyrrole and imidazole triamide analogs of distamycin. BIOORGAN MED CHEM , 15 (1) 474 - 483. 10.1016/j.bmc.2006.09.037.

Buchler, T; Bomanji, J; Lee, SM; (2007) FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity. Haematologica , 92 (11) e120-e121. 10.3324/haematol.11856. Gold open access

C

Chowdhury, T.; (2007) Investigation of the role of MLL-ENL in leukaemogenesis. Doctoral thesis, University of London. Green open access
file

Clingen, PH; Arlett, CF; Hartley, JA; Parris, CN; (2007) Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links. EXP CELL RES , 313 (4) 753 - 760. 10.1016/j.yexcr.2006.11.007.

Cutillas, PR; Vanhaesebroeck, B; (2007) Quantitative profile of five murine core proteomes using label-free functional proteomics. MOLECULAR & CELLULAR PROTEOMICS , 6 (9) pp. 1560-1573. 10.1074/mcp.M700037-MCP200.

D

Dancey, G; Violet, J; Othman, S; Parker, S; Green, A; Sharma, S; Francis, R; (2007) Phase I trial of the I-131-labelled Anti-CD25 antibody basiliximab in the treatment of patients with relapsed or refractory lymphoma. In: BLOOD. (pp. 199A - 200A). AMER SOC HEMATOLOGY

Dearling, JL; Pedley, RB; (2007) Technological advances in radioimmunotherapy. Clin Oncol (R Coll Radiol) , 19 (6) pp. 457-469. 10.1016/j.clon.2007.03.016.

Dearling, JLJ; Qureshi, U; Begent, RHJ; Pedley, RB; (2007) Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy. CLIN CANCER RES , 13 (6) 1903 - 1910. 10.1158/1078-0432.CCR-06-2094.

de Bruin, EC; van de Pas, S; van de Velde, CJ; van Krieken, JH; Peltenburg, LT; Marijnen, CA; Medema, JP; (2007) Gene expression profiling reveals two separate mechanisms regulating apoptosis in rectal carcinomas in vivo. Apoptosis , 12 (9) pp. 1671-1680. 10.1007/s10495-007-0088-2.

de Heer, P; Gosens, MJ; de Bruin, EC; Dekker-Ensink, NG; Putter, H; Marijnen, CA; van den Brule, AJ; (2007) Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy. Clin Cancer Res , 13 (10) pp. 2955-2960. 10.1158/1078-0432.CCR-06-2042.

de Heer, P; de Bruin, EC; Klein-Kranenbarg, E; Aalbers, RI; Marijnen, CA; Putter, H; de Bont, HJ; (2007) Caspase-3 activity predicts local recurrence in rectal cancer. Clin Cancer Res , 13 (19) pp. 5810-5815. 10.1158/1078-0432.CCR-07-0343.

E

Eickholt, BJ; Ahmed, AI; Davies, M; Papakonstanti, EA; Pearce, W; Starkey, ML; Bilando, A; (2007) Control of Axonal Growth and Regeneration of Sensory Neurons by the p110 delta PI 3-Kinase. PLOS ONE , 2 (9) , Article e869. 10.1371/journal.pone.0000869. Green open access
file

El Emir, E; Qureshi, U; Dearling, JLJ; Boxer, GM; Clatworthy, I; Folarin, AA; Robson, MP; (2007) Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas. CANCER RES , 67 (24) 11896 - 11905. 10.1158/0008-5472.CAN-07-2967.

El-Emir, E; Dearling, JLJ; Huhalov, A; Robson, MP; Boxer, G; Neri, D; van Dongen, GAMS; (2007) Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models. BRIT J CANCER , 96 (12) 1862 - 1870. 10.1038/sj.bjc.6603806. Gold open access

Ellis, T; Evans, DA; Martin, CRH; Hartley, JA; (2007) A 96-well DNase I footprinting screen for drug-DNA interactions. NUCLEIC ACIDS RES , 35 (12) , Article e89. 10.1093/nar/gkm467. Gold open access

F

Forster, M; Kaye, S; Oza, A; Sklenar, I; Johri, A; Cheung, W; Zaknoen, S; (2007) A phase Ib and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancer. Clin Cancer Res , 13 (14) pp. 4178-4184. 10.1158/1078-0432.CCR-06-1653.

Forster, MD; Ormerod, MG; Agarwal, R; Kaye, SB; Jackman, AL; (2007) Flow cytometric method for determining folate receptor expression on ovarian carcinoma cells. Cytometry A , 71 (11) pp. 945-950. 10.1002/cyto.a.20456.

Fox, J; Glasspool, D; Grecu, D; Modgil, S; South, M; Patkar, V; (2007) Argumentation-based inference and decision making - A medical perspective. IEEE INTELL SYST , 22 (6) 34 - 41.

Funes, JM; Quintero, M; Henderson, S; Martinez, D; Qureshi, U; Westwood, C; Clements, MO; (2007) Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. P NATL ACAD SCI USA , 104 (15) 6223 - 6228. 10.1073/pnas.0700690104. Gold open access

Furnari, FB; Fenton, T; Bachoo, RM; Mukasa, A; Stommel, JM; Stegh, A; Hahn, WC; (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev , 21 (21) pp. 2683-2710. 10.1101/gad.1596707.

G

Geering, B; Cutillas, PR; Nock, G; Gharbi, SI; Vanhaesebroeck, B; (2007) Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 104 (19) pp. 7809-7814. 10.1073/pnas.0700373104.

Geering, B; Cutillas, PR; Vanhaesebroeck, B; (2007) Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits? In: (Proceedings) 3rd Focused Meeting on PI3K Signalling and Disease. (pp. pp. 199-203). PORTLAND PRESS LTD

Gunaratnam, M; Greciano, O; Martins, C; Reszka, AP; Schultes, CM; Morjani, H; Riou, JF; (2007) Mechanism of acridine-based telomerase inhibition and telomere shortening. Biochem Pharmacol , 74 (5) pp. 679-689. 10.1016/j.bcp.2007.06.011.

H

Hochhauser, D; Kotecha, M; O'Hare, C; Morris, PJ; Hartley, JM; Taherbhai, Z; Harris, D; (2007) Modulation of topoisomerase II alpha expression by a DNA sequence-specific polyamide. MOL CANCER THER , 6 (1) 346 - 354. 10.1158/1535-7163.MCT-06-0503.

Howie, AJ; (2007) The association among C4d staining in renal transplant biopsies, the production of donor-specific HLA antibodies, and graft outcome. Transplantation , 83 (4) pp. 373-374. 10.1097/01.tp.0000251424.65487.5c.

J

Jain, P; Cerone, MA; Leblanc, AC; Autexier, C; (2007) Telomerase and neuronal marker status of differentiated NT2 and SK-N-SH human neuronal cells and primary human neurons. J Neurosci Res , 85 (1) pp. 83-89. 10.1002/jnr.21094.

Ji, H; Rintelen, F; Waltzinger, C; Bertschy Meier, D; Bilancio, A; Pearce, W; Hirsch, E; (2007) Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. Blood , 110 (8) pp. 2940-2947. 10.1182/blood-2007-04-086751.

Joerger, M; Huitema, ADR; Richel, DJ; Dittrich, C; Pavlidis, N; Briasoulis, E; Vermorken, JB; (2007) Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: A study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group. CLIN CANCER RES , 13 (21) 6410 - 6418. 10.1158/1078-0432.CCR-07-0064.

Jones, AM; Thirlwell, C; Howarth, KM; Graham, T; Chambers, W; Segditsas, S; Page, KM; (2007) Analysis of copy number changes suggests chromosomal instability in a minority of large colorectal adenomas. J PATHOL , 213 (3) 249 - 256. 10.1002/path.2234.

K

Kandola, S; Anyamene, N; Payne, H; Harland, S; (2007) Transdermal oestrogen therapy as a second-line hormonal intervention in prostate cancer: a bad experience. BJU INTERNATIONAL , 99 (1) pp. 53-55. 10.1111/j.1464-410X.2007.06543.x.

Kiakos, K; Sato, A; Asao, T; McHugh, PJ; Lee, M; Hartley, JA; (2007) DNA sequence-selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz[e]indolone analogue of duocarmycin AS-I-145. MOL CANCER THER , 6 (10) 2708 - 2718. 10.1158/1535-7163.MCT-07-0294.

Kiakos, K.; (2007) Molecular and cellular pharmacology of novel chiral and achiral CC-1065/duocarmycin analogues. Doctoral thesis, University of London. Green open access
file

Kishimoto, H; Ohteki, T; Yajima, N; Kawahara, K; Natsui, M; Kawarasaki, S; Hamada, K; (2007) The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. Blood , 109 (8) pp. 3316-3324. 10.1182/blood-2006-07-038059.

Koch, CM; Andrews, RM; Flicek, P; Dillon, SC; Karaoz, U; Clelland, GK; Wilcox, S; (2007) The landscape of histone modifications across 1% of the human genome in five human cell lines. GENOME RES , 17 (6) 691 - 707. 10.1101/gr.5704207.

Kogelberg, H; Tolner, B; Sharma, SK; Lowdell, MW; Qureshi, U; Robson, M; Hillyer, T; (2007) Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy. GLYCOBIOLOGY , 17 (1) 36 - 45. 10.1093/glycob/cwl053.

Kulkarni, AA; Loddo, M; Leo, E; Rashid, M; Eward, KL; Fanshawe, TR; Butcher, J; (2007) DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. CLIN CANCER RES , 13 (20) 6153 - 6161. 10.1158/1078-0432.CCR-07-0671.

L

Lai, P; Bomanji, JB; Mahmood, S; Nagabhushan, N; Syed, R; Gacinovic, S; Lee, SM; (2007) Detection of tumour thrombus by (18)F-FDG-PET/CT imaging. EUROPEAN JOURNAL OF CANCER PREVENTION , 16 (1) pp. 90-94. 10.1097/01.cej.0000220641.46470.77.

Lankester, KJ; Maxwell, RJ; Pedley, RB; Dearling, JL; Qureshi, UA; El-Emir, E; Hill, SA; (2007) Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, I-131-A5B7, even at doses that are sub-optimal for vascular shut-down. INT J ONCOL , 30 (2) 453 - 460.

Lee, S-M; Woll, PJ; James, LE; Hatton, M; Ali, K; Spiro, SG; Ali, SR; (2007) A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC). In: (pp. S306-S307). LIPPINCOTT WILLIAMS & WILKINS

Lee, S-M; Woll, PJ; Rudd, RM; Gower, NH; Ottensmeier, CH; Ali, K; Spiro, SG; (2007) A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC). In: (pp. S359-S359). LIPPINCOTT WILLIAMS & WILKINS

Lewis, IJ; Nooij, MA; Whelan, J; Sydes, MR; Grimer, R; Hogendoorn, PCW; Memon, MA; (2007) Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. J NATL CANCER I , 99 (2) 112 - 128. 10.1093/inci/djk015.

M

Maloney, A; Clarke, PA; Naaby-Hansen, S; Stein, R; Koopman, J-O; Akpan, A; Yang, A; (2007) Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. CANCER RESEARCH , 67 (7) pp. 3239-3253. 10.1158/0008-5472.CAN-06-2968.

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davies, N; Tibballs, J; (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol , 30 (1) pp. 6-25. 10.1007/s00270-006-0062-3.

Martins, C; Gunaratnam, M; Stuart, J; Makwana, V; Greciano, O; Reszka, AP; Kelland, LR; (2007) Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents. Bioorg Med Chem Lett , 17 (8) pp. 2293-2298. 10.1016/j.bmcl.2007.01.056.

McCloskey, EV; Beneton, M; Charlesworth, D; Kayan, K; deTakats, D; Dey, A; Orgee, J; (2007) Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res , 22 (1) pp. 135-141. 10.1359/jbmr.061008.

Milroy, LG; Zinzalla, G; Prencipe, G; Michel, P; Ley, SV; Gunaratnam, M; Beltran, M; (2007) Chemical variation of natural-product-like scaffolds: design, synthesis, and biological activity of fused bicyclic acetal derivatives. Angew Chem Int Ed Engl , 46 (14) pp. 2493-2496. 10.1002/anie.200604688.

N

Nashed, BF; Zhang, T; Al-Alwan, M; Srinivasan, G; Halayko, AJ; Okkenhaug, K; Vanhaesebroeck, B; (2007) Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur J Immunol , 37 (2) pp. 416-424. 10.1002/eji.200636401.

Nehls, O; Okech, T; Hsieh, CJ; Enzinger, T; Sarbia, M; Borchard, F; Gruenagel, HH; (2007) Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. Br J Cancer , 96 (9) pp. 1409-1418. 10.1038/sj.bjc.6603728.

Ng, F; Mastoroudes, H; Paul, E; Davies, N; Tibballs, J; Hochhauser, D; Mayer, A; (2007) A comparison of hickman line- and port-a-cath-associated complications in patients with solid tumours undergoing chemotherapy. CLIN ONCOL-UK , 19 (7) 551 - 556. 10.1016/j.clon.2007.04.003.

O

O'Hare, CC; Uthe, P; Mackay, H; Blackmon, K; Jones, J; Brown, T; Nguyen, B; (2007) Sequence recognition in the minor groove of DNA by covalently linked formamido imidazole-pyrrole-imidazole polyamides: Effect of H-pin linkage and linker length on selectivity and affinity. BIOCHEMISTRY-US , 46 (42) 11661 - 11670. 10.1021/bi701053a.

Okkenhaug, K; Ali, K; Vanhaesebroeck, B; (2007) Antigen receptor signalling: a distinctive role for the p110 delta isoform of Pl3K. TRENDS IN IMMUNOLOGY , 28 (2) 80 - 87. 10.1016/j.it.12.007.

Okkenhaug, K; Ali, K; Vanhaesebroeck, B; (2007) Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K. Trends in Immunology , 28 (2) 80 - 87. 10.1016/j.it.2006.12.007. Green open access
file

P

Papakonstanti, EA; Ridley, AJ; Vanhaesebroeck, B; (2007) The p110 delta isoform of PI 3-kinase negatively controls RhoA and PTEN. EMBO JOURNAL , 26 (13) pp. 3050-3061. 10.1038/sj.emboj.7601763.

Penn, H; Howie, AJ; Kingdon, EJ; Bunn, CC; Stratton, RJ; Black, CM; Burns, A; (2007) Scleroderma renal crisis-patient characteristics and outcomes in 110 cases from a single centre. In: RHEUMATOLOGY. (pp. I4 - I5). OXFORD UNIV PRESS

Penn, H; Howie, AJ; Kingdon, EJ; Bunn, CC; Stratton, RJ; Black, CM; Burns, A; (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM-INT J MED , 100 (8) 485 - 494. 10.1093/qjmed/hcm052.

Pepper, C; Lowe, H; Fegan, C; Thurieau, C; Thurston, DE; Hartley, JA; Delavault, P; (2007) Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells. BRIT J CANCER , 97 (2) 253 - 259. 10.1038/sj.bjc.6603853.

Pipinikas, CP; Nair, SB; Kirby, RS; Carter, ND; Fenske, CD; (2007) Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study. Biomarkers , 12 (5) pp. 541-557. 10.1080/13547500701391353.

Plummer, ER; Calvert, H; (2007) Targeting poly(ADP-ribose) polymerase: A two-armed strategy for cancer therapy. CLIN CANCER RES , 13 (21) 6252 - 6256. 10.1158/1078-0432.CCR-07-0617.

Plummer, R; Attard, G; Pacey, S; Li, L; Razak, A; Perrett, R; Barrett, M; (2007) Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers. CLIN CANCER RES , 13 (20) 6187 - 6194. 10.1158/1078-0432.CCR-07-0950.

Porschen, R; Arkenau, HT; Kubicka, S; Greil, R; Seufferlein, T; Freier, W; Kretzschmar, A; (2007) Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group. J Clin Oncol , 25 (27) pp. 4217-4223. 10.1200/JCO.2006.09.2684.

R

Rachid, Z; Brahimi, F; Qiu, Q; Williams, C; Hartley, JM; Hartley, JA; Jean-Claude, BJ; (2007) Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: Discovery of an unusual structure-activity relationship. J MED CHEM , 50 (11) 2605 - 2608. 10.1021/jm070144p.

Rades, D; Veninga, T; Stalpers, LJ; Basic, H; Hoskin, PJ; Karstens, JH; Schild, SE; (2007) Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys , 67 (5) pp. 1506-1509. 10.1016/j.ijrobp.2006.11.029.

Roylance, R; Seddon, B; McTiernan, A; Sykes, K; Daniels, S; Whelan, J; (2007) Experience of the use of trabectedin (ET-743, Yondelis (TM)) in 21 patients with pre-treated advanced sarcoma from a single centre. CLIN ONCOL-UK , 19 (8) 572 - 576. 10.1016/j.cton.2007.05.006.

Rustin, GJ; Mead, GM; Stenning, SP; Vasey, PA; Aass, N; Huddart, RA; Sokal, MP; (2007) Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197 - The National Cancer Research Institute Testis Cancer Clinical Studies Group. JOURNAL OF CLINICAL ONCOLOGY , 25 (11) 1310 - 1315. 10.1200/JCO.2006.08.4889.

S

Short, SC; Buffa, FM; Bourne, S; Koritzinsky, M; Wouters, BG; Bentzen, SM; (2007) Dose- and time-dependent changes in gene expression in human glioma cells after low radiation doses. RADIATION RESEARCH , 168 (2) pp. 199-208. 10.1667/RR0940.1.

Singh, KL; Muttukrishna, S; Stein, RC; McGarrigle, HH; Patel, A; Parikh, B; Groome, NP; (2007) Predictors of ovarian reserve in young women with breast cancer. BRIT J CANCER , 96 (12) 1808 - 1816. 10.1038/sj.bjc.6603814. Gold open access

Smith, AE; Pinkney, M; Piggott, NH; Calvert, H; Milton, ID; Lunec, J; (2007) Novel monoclonal antibody for detection of folate receptor alpha in paraffin-embedded tissues. HYBRIDOMA , 26 (5) 281 - 288. 10.1089/hyb.2007.0512.

Strauss, SJ; Higginbottom, K; Jüliger, S; Maharaj, L; Allen, P; Schenkein, D; Lister, TA; (2007) The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines. Cancer Res , 67 (6) pp. 2783-2790. 10.1158/0008-5472.CAN-06-3254.

Sullivan, A; Lu, X; (2007) ASPP: a new family of oncogenes and tumour suppressor genes. BRITISH JOURNAL OF CANCER , 96 (2) pp. 196-200. 10.1038/sj.bjc.6603525.

Swanton, C; Marani, M; Pardo, O; Warne, PH; Kelly, G; Sahai, E; Elustondo, F; (2007) Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. CANCER CELL , 11 (6) pp. 498-512. 10.1016/j.ccr.2007.04.011.

Swanton, C; Nicke, B; Marani, M; Kelly, G; Downward, J; (2007) Initiation of high frequency multi-drug resistance following kinase targeting by siRNAs. Cell Cycle , 6 (16) pp. 2001-2004. 10.4161/cc.6.16.4538.

T

Thirlwell, C; Howarth, KM; Segditsas, S; Guerra, G; Thomas, HJW; Phillips, RKS; Talbot, IC; (2007) Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations. BRIT J CANCER , 96 (11) 1729 - 1734. 10.1038/sj.bjc.6603789.

Tolner, B; Smith, L; Hillyer, T; Bhatia, J; Beckett, P; Robson, L; Sharma, SK; (2007) From laboratory to Phase I/II cancer trials with recombinant biotherapeutics. EUR J CANCER , 43 (17) 2515 - 2522. 10.1016/j.ejca.2007.08.027.

Toumpanakis, C; Meyer, T; Caplin, ME; (2007) Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM , 21 (1) pp. 131-144. 10.1016/j.beem.2007.01.005.

U

Ullah, MZ; Bhargava, A; Jamal-Hanjani, M; Jacob, S; (2007) Totally extra-peritoneal repair of inguinal hernia by a glove-balloon: technical innovation. Surgeon , 5 (4) pp. 245-247.

V

Vassileva, V; Grant, J; De Souza, R; Allen, C; Piquette-Miller, M; (2007) Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. CANCER CHEMOTHERAPY AND PHARMACOLOGY , 60 (6) pp. 907-914. 10.1007/s00280-007-0449-0.

W

Westbury, CB; Pearson, A; Nerurkar, A; Reis-Filho, JS; Steele, D; Peckitt, C; Sharp, G; (2007) Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride. BRIT J RADIOL , 80 (959) 934 - 938. 10.1259/bjr/25046649.

Whelan, J; Dolbear, C; Mak, V; Moller, H; Davies, E; (2007) Where do teenagers and young adults receive treatment for cancer? J PUBLIC HEALTH-UK , 29 (2) 178 - 182. 10.1093/pubmed/fdm006.

Wood, KA; Hoskin, PJ; Saunders, MI; (2007) Positron emission tomography in oncology: A review. CLIN ONCOL-UK , 19 (4) 237 - 255. 10.1016/j.clon.2007.02.001.

Wynne, P; Newton, C; Ledermann, J; Olaitan, A; Mould, TA; Hartley, JA; (2007) Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy. BRIT J CANCER , 97 (7) 927 - 933. 10.1038/sj.bjc.6603973.

This list was generated on Sun Dec 4 03:34:53 2016 GMT.